Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Labetalol for chronic hypertension in pregnancy
PACTR201707002463243Completed
- Sponsor
- Faculty of Medicine
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of labetalol and methyldopa in chronic hypertension in pregnancy (CHTN) (3 arms), sponsored by Faculty of Medicine. Started Aug 2017; status: completed.
02
Drugs
labetalolmethyldopa
03
Conditions
chronic hypertension in pregnancy (CHTN)
Beyond the preview
Go deeper on PACTR201707002463243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201707002463243.